Year 2020 đ
The current video has no audio description in either format.
Use the following form to set your preferences related to audio description.
Category: neuroscience – Page 490
In the philosophy of mind, the multiple realizability thesis contends that a single mental kind (property, state, event) can be realized by many distinct physical kinds. A common example is pain. Many philosophers have asserted that a wide variety of physical properties, states, or events, sharing no features in common at that level of description, can all realize the same pain. This thesis served as a premise in the most influential argument against early theories that identified mental states with brain states (psychoneural, or mind-brain identity theories). It also served in early arguments for functionalism. Nonreductive physicalists later adopted this premise and these arguments (usually without alteration) to challenge all varieties of psychophysical reductionism. The argument was even used to challenge the functionalism it initially was offered to support. Reductionists (and other critics) quickly offered a number of responses, initially attacking either the anti-reductionist or anti-identity conclusion from the multiple realizability premise, or advocating accounts of the reduction relation that accommodated multiple realizability. More recently it has become fashionable to attack the multiple realizability premise itself. Most recently the first book-length treatment of multiple realizability and its philosophical import has appeared.
This entry proceeds mostly chronologically, to indicate the historical development of the topic. Its principle focus is on philosophy of mind and cognitive science, but it also indicates the more recent shift in emphasis to concerns in the metaphysics of science more generally. It is worth mentioning at the outset that multiple realizability has been claimed in physics (e.g., Batterman 2000), biochemistry (Tahko forthcoming) and synthetic biology (Koskinen 2019a, b). After more than fifty years of detailed philosophical discussion there still seems to be no end in sight for novel ideas about this persistent concern.
A recent study shows that consuming high levels of sodium is associated with cognitive decline. On the flip side, the findings suggest that diets high in potassium are associated with higher levels of cognitive function.
In Episode 10 we explore the Matrioshka Brain, a nested Layer type of Dyson Sphere designed to turn stars in to giant computers, and conclude our look at Dyson Spheres and other types of Stellar Engines.
Support the Channel on Patreon:
https://www.patreon.com/IsaacArthur.
Listen or Download the audio of this episode from Soundcloud:
https://soundcloud.com/isaac-arthur-148927746/ms10-matrioshka-brains.
Support the Channel on Patreon:
https://www.patreon.com/user?ty=h&u=3365828
Original Paper on Matrioshka Brains by RJ Bradbury:
https://www.gwern.net/docs/1999-bradbury-matrioshkabrains.pdf.
More art by Jakub Grygier:
Human beings can sometimes experience dissociative states, moments in which they feel disconnected from their body and the world around them. While these states have been linked to many psychiatric conditions, they can also be elicited by the intake of some legal and illegal drugs.
One of the most renowned dissociation-inducing drugs is ketamine, an anesthetic commonly used to sedate patients or reduce pain resulting from medical procedures. In recent years, ketamine has also been found to be a potentially valuable treatment for some cases of depression.
While several studies have investigated the therapeutic effects of this strong anesthetic, so far very little is known about the cellular and neuronal mechanisms behind the dissociative states it produces. A paper by a team of researchers at University of Pennsylvania, recently published in Nature Neuroscience, might shed some light on these so far elusive processes.
The sick childâs prognosis, who had not responded to conventional treatment, was bleak. Nevertheless, a group of doctors from Rutgers University thought there could be hope despite the conventional wisdom against pursuing any further treatment.
What transpired over the following several weeks in the fall of 2020, described in a case study recently published in the European Medical Journal, was notable and representative of a newer approach to effectively treating a strange disease, the doctors stated.
The study focuses on the medical case of a 5-year-old girl who suffered from anti-NMDAR (N-methyl-D-aspartate receptor) encephalopathy, a rare and difficult-to-diagnose malfunction of the brain. Unresponsive to treatments, the child had been transferred to a rehabilitation center and been in a catatonic state for three months when a team of Rutgers physicians were called in to help.
A team of researchers from Vrije Universiteit Amsterdam in the Netherlands and the Veterans Administration in the U.S. has conducted a genome-wide association study looking into genetic overlap between 12 common psychiatric disorders. The group describes profiling pleiotropic genetic incidences to 12 common psychiatric disorders in their paper published in the journal Nature Genetics.
Many years ago, psychiatrists and other medical professionals preferred to think of psychiatric conditions as separate diseases, unrelated to one another. More recently, genetics findings involved in psychiatric disorders have suggested that not only are some of them related, but some have overlap, which suggests that illnesses such as autism might have multiple forms, giving rise to a spectrum of diseases.
In this new effort, the research team conducted a cross-examination of 12 psychiatric disorders, looking specifically for genetic overlap. Their work involved conducting a cross-trait meta-analysis to study the impact of single-nucleotide polymorphisms (SNPs), genes in general, cells, pathways and tissue types that might be shared by the 12 disorders ADHD, alcoholism, anorexia, anxiety disorder, autism, bipolarism, depression, OCD, PTSD, schizophrenia and Tourette syndrome.
Bernardo Kastrup, Carlo Rovelli and Patricia Churchland lock horns over the New Science of Consciousness.
00:00 Intro.
01:20 Patricia Churchland | On scientific evidence.
02:50 Bernardo Kastrup | On material idealism.
04:47 Carlo Rovelli | There is no hard problem of consciousness.
07:00 Robert Lawrence Kuhn | Will we ever be able to provide data explaining consciousness?
Watch the full debate at https://iai.tv/video/the-new-science-of-consciousness?utm_soâŠescription.
We are uncovering a new science of consciousness. A theory that is getting closer to solving the problem of the self once and for all. Or at least so claim leading neuroscientists. Some argue the reality we perceive is a controlled hallucination as a best guess to how the world really is. Others that quantum mechanics or multiple levels of brain organisation are responsible for consciousness. But critics maintain these donât get to the heart of the problem: how the material stuff of the brain is responsible for the immaterial stuff of experience.
Should we see the ânew science of consciousnessâ as marketing hype? Might we alternatively need to give up our very notion of reality? Or could science be about to crack the ancient problem of the self once and for all?
#TheNewScienceOfConsciousness #IsQuantumTheKey #DataConsciousness.
According to an exclusive report by Reuters, Elon Muskâs Neuralink is facing a federal probe to investigate claims of unnecessary animal welfare violations.
According to an exclusive report by Reuters, the medical device company Neuralink, owned by Elon Musk, is reportedly under federal investigation for possible animal welfare violations. The investigation comes from internal staff complaints that its animal testing is being rushed, resulting in needless suffering and deaths.
However, it is important to note that Neuralink has a robust commitment to animal welfare within its organization.
Alzheimerâs disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimerâs disease, but there are medications that can help ease the symptoms.